SRZN
SurrozenCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
SRZN vs peer average
67/100
SRZN vs. peer average (C vs. D)
Grade spread
A 1 · B 1 · D 3 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RANI is the first available peer comparator.
Clinical-stage biotech peer from the prior baseline set; useful mainly as an event-volatility and financing-risk comparator rather than a direct ophthalmology operating match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SRZN
Surrozen
RANI
Rani Therapeutics
Grade
C
B
Momentum
12
85
Value
41
41
Sentiment
94
57
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs RANI
SRZN / RANI
Grade Position
In line
SRZN vs. peer average (C vs. D)
67/100
Momentum
12
RANIValue
41
SRZNSentiment
94
SRZNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SRZN
RANI is the first peer returned for this comparison set.